InvestSMART

Cyclopharm Limited (ASX: CYC) - Announcements

Current share price for CYC : $0.450 0.01 (2.17%)+

ASX company news and announcements for Cyclopharm Limited (CYC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cyclopharm Limited (CYC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cyclopharm Limited (CYC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cyclopharm Limited (CYC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$57 Half Yearly Report and Accounts 27 Aug 2024 8:40AM $1.415 $0.450 fallen by 68.20%
$57 Cleansing Notice 28 Jun 2024 5:23PM $1.690 $0.450 fallen by 73.37%
$57 Application for quotation of securities - CYC 28 Jun 2024 5:21PM $1.690 $0.450 fallen by 73.37%
$57 Proposed issue of securities - CYC 28 Jun 2024 2:06PM $1.710 $0.450 fallen by 73.68%
$57 Change of Director's Interest Notice - KB 28 Jun 2024 9:47AM $1.760 $0.450 fallen by 74.43%
$57 Change of Director's Interest Notice - DA 28 Jun 2024 9:46AM $1.760 $0.450 fallen by 74.43%
$57 Change of Director's Interest Notice - DH 28 Jun 2024 9:46AM $1.760 $0.450 fallen by 74.43%
$57 Application for quotation of securities - CYC 28 Jun 2024 9:43AM $1.760 $0.450 fallen by 74.43%
$57 Appendix 3B 27 Jun 2024 4:34PM $1.760 $0.450 fallen by 74.43%
$57 Update - Proposed issue of securities - CYC 27 Jun 2024 4:33PM $1.760 $0.450 fallen by 74.43%
$57 Update - Proposed issue of securities - CYC 25 Jun 2024 4:39PM $1.615 $0.450 fallen by 72.14%
$57 Cyclopharm completes oversubscribed Share Purchase Plan 25 Jun 2024 9:09AM $1.595 $0.450 fallen by 71.79%
$57 USA Reimbursement Update for TECHNEGAS 24 Jun 2024 9:09AM $1.500 $0.450 fallen by 70%
$57 Cyclopharm Presenting at Macquarie Emerging Leaders Conf 19 Jun 2024 8:28AM $1.530 $0.450 fallen by 70.59%
$57 Change in substantial holding AACCF 11 Jun 2024 8:05AM $1.595 $0.450 fallen by 71.79%
$57 Change in substantial holding Chemical Overseas 11 Jun 2024 8:01AM $1.595 $0.450 fallen by 71.79%
$57 Change in substantial holding Barings 11 Jun 2024 8:01AM $1.595 $0.450 fallen by 71.79%
$57 Change in substantial holding from CVC 5 Jun 2024 4:48PM $1.695 $0.450 fallen by 73.45%
$57 TECHNEGAS Awarded US Pass-Through Reimbursemt Status 5 Jun 2024 10:31AM $1.400 $0.450 fallen by 67.86%
$57 Cleansing Statement - Placement 4 Jun 2024 1:45PM $1.420 $0.450 fallen by 68.31%
$57 Update - Application for quotation of securities - CYC 4 Jun 2024 12:22PM $1.420 $0.450 fallen by 68.31%
$57 CYC Results of AGM Poll - Addendum 4 Jun 2024 8:36AM $1.420 $0.450 fallen by 68.31%
$57 Change of Director's Interest Notice - GK 3 Jun 2024 5:56PM $1.420 $0.450 fallen by 68.31%
$57 Change in substantial holding 3 Jun 2024 5:42PM $1.420 $0.450 fallen by 68.31%
$57 Share Purchase Plan Offer Booklet 31 May 2024 9:28AM $1.380 $0.450 fallen by 67.39%

101 - 125 of 612 results

Page 5 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.